Literature DB >> 10068316

Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.

M K Njenga1, P D Murray, D McGavern, X Lin, K M Drescher, M Rodriguez.   

Abstract

We previously showed that Theiler's murine encephalomyelitis virus (TMEV)-infected major histocompatibility complex (MHC) class II-deficient mice develop both demyelination and neurologic deficits, whereas MHC class I-deficient mice develop demyelination but no neurologic deficits. The absence of neurologic deficits in the class I-deficient mice was associated with preserved sodium channel densities in demyelinated lesions, a relative preservation of axons, and extensive spontaneous remyelination. In this study, we investigated whether TMEV-infected class II-deficient mice, which have an identical genetic background (C57BL/6 x 129) as the class I-deficient mice, have preserved axons and spontaneous myelin repair following chronic TMEV-infection. Both class I- and class II-deficient mice showed similar extents of demyelination of the spinal cord white matter 4 months after TMEV infection. However, the class I-deficient mice demonstrated remyelination by oligodendrocytes, whereas class II-deficient mice showed minimal if any myelin repair. Demyelinated lesions, characterized by inflammatory infiltrates in both mutants, revealed disruption of axons in class II- but not class I-deficient mice. Further characterization revealed that even though class II-deficient mice lacked TMEV-specific IgG, they had virus-specific IgM, which, however, did not neutralize TMEV in vitro. In addition, class II-deficient mice developed TMEV-specific cytotoxic T-lymphocytes in the CNS during the acute (7 days) disease, but these cytotoxic lymphocytes were not present in the chronic stage of disease, despite a high titer of infectious virus throughout the disease. We envision that the presence of demyelination, high virus titer, absence of remyelination, and axonal disruption in chronically infected class II-deficient mice contributes to the development of paralytic disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068316      PMCID: PMC5444470          DOI: 10.1097/00005072-199901000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  55 in total

1.  The longstanding MS lesion. A quantitative MRI and electron microscopic study.

Authors:  D Barnes; P M Munro; B D Youl; J W Prineas; W I McDonald
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

2.  The effect of the platelet derived wound healing formula and the nerve growth factor on the experimentally injured spinal cord.

Authors:  Y Hiraizumi; E Fujimaki; E E Transfeldt; N Kawahara; V D Fiegel; D Knighton; J H Sung
Journal:  Spinal Cord       Date:  1996-07       Impact factor: 2.772

3.  Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter.

Authors:  R J Franklin; S A Bayley; R Milner; C Ffrench-Constant; W F Blakemore
Journal:  Glia       Date:  1995-01       Impact factor: 7.452

4.  A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes.

Authors:  D J Miller; M Rodriguez
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

5.  Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.

Authors:  M Rodriguez; A J Dunkel; R L Thiemann; J Leibowitz; M Zijlstra; R Jaenisch
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

Review 6.  Animal models of demyelination.

Authors:  M K Njenga; M Rodriguez
Journal:  Curr Opin Neurol       Date:  1996-06       Impact factor: 5.710

7.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

Authors:  S Komoly; L D Hudson; H D Webster; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 8.  Remyelination in the central nervous system and the peripheral nervous system.

Authors:  S K Ludwin
Journal:  Adv Neurol       Date:  1988

9.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.

Authors:  C S Raine; L Scheinberg; J M Waltz
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

10.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  7 in total

1.  Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; S Sathornsumetee; M Rodriguez
Journal:  Brain       Date:  2001-07       Impact factor: 13.501

Review 2.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

Review 3.  Glia Disease and Repair-Remyelination.

Authors:  Robin J M Franklin; Steven A Goldman
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-05-18       Impact factor: 10.005

4.  Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration.

Authors:  Heather A Arnett; Ying Wang; Glenn K Matsushima; Kinuko Suzuki; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

5.  Human class I major histocompatibility complex alleles determine central nervous system injury versus repair.

Authors:  Bharath Wootla; Aleksandar Denic; Jens O Watzlawik; Arthur E Warrington; Laurie J Zoecklein; Louisa M Papke-Norton; Chella David; Moses Rodriguez
Journal:  J Neuroinflammation       Date:  2016-11-17       Impact factor: 8.322

Review 6.  Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

Authors:  A E Warrington; M Rodriguez
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.

Authors:  Miriam Mecha; Francisco J Carrillo-Salinas; Leyre Mestre; Ana Feliú; Carmen Guaza
Journal:  Prog Neurobiol       Date:  2012-11-29       Impact factor: 11.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.